FDA
approval
· 2018-12-03
FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Original Application (ScieGen Pharmaceuticals, Inc)
Summary
FDA approved the original application for a generic fixed-dose combination of amlodipine and olmesartan medoxomil for hypertension. The product is manufactured …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)